SCHEMBL13870813

SCHEMBL13870813

Cc1cc(C)cc(-c2nc3cc(C)c(C)cc3cc2C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ CYP1A2 P05177 4/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TYR P14679 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TERT O14746 1/20 0.32
▸ GAA P10253 2/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ MAPK14 Q16539 1/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870788 0.84 PDE10A (0.46) MAPTKDM4EPDE3BPDE3ACYP1A2
SCHEMBL13870814 0.82 CYP1A2 (0.41) MAPTKDM4EPDE3BPDE3ACYP1A2
SCHEMBL13870815 0.82 CYP1A2 (0.42) MAPTKDM4ECYP1A2POLBCA2
SCHEMBL13870830 0.76 KDM4E (0.42) MAPTKDM4EPDE3BPDE3ACYP2C19
SCHEMBL13870816 0.75 PDE3B (0.38) KDM4EPDE3BPDE3ACYP1A2PDE10A
SCHEMBL13870806 0.73 PDE3B (0.38) MAPTKDM4EPDE3BPDE3ACYP1A2
SCHEMBL13870799 0.73 MAPT (0.36) MAPTKDM4EPDE3BPDE3ACYP1A2
SCHEMBL13870826 0.73 PDGFRB (0.39) MAPTKDM4EPDE3BPDE3APDE10A
SCHEMBL13399655 0.72 PDE10A (0.40) MAPTKDM4EPDE3BPDE3ACYP1A2
SCHEMBL13870807 0.72 PDE10A (0.44) MAPTKDM4EPDE10AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 MAPT 1550/4885KDM4E 2874/4885PDE3B 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback